These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 31530356)
1. [Analysis of 30 cases of inherited cardiac arrhythmia syndrome in children]. Li ZL; Zeng SY; Liang DP; Liu T; Wang SS; Zhang ZW Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):700-704. PubMed ID: 31530356 [No Abstract] [Full Text] [Related]
2. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. Dohadwala M; Link MS Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Kaufman ES Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908 [TBL] [Abstract][Full Text] [Related]
4. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome. Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214 [TBL] [Abstract][Full Text] [Related]
5. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262 [TBL] [Abstract][Full Text] [Related]
6. Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). Singh M; Morin DP; Link MS Prog Cardiovasc Dis; 2019; 62(3):227-234. PubMed ID: 31078562 [TBL] [Abstract][Full Text] [Related]
8. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes. Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F; Jarman JW; Clague JR; Till J Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Schinkel AF Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907 [TBL] [Abstract][Full Text] [Related]
11. [Cardiac channelopathies in the context of hereditary arrhythmia syndromes]. Huttelmaier MT; Fischer TH Inn Med (Heidelb); 2024 Aug; 65(8):787-797. PubMed ID: 38977442 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy. Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288 [TBL] [Abstract][Full Text] [Related]
13. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430 [TBL] [Abstract][Full Text] [Related]
14. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT. Schimpf R; Veltmann C; Wolpert C; Borggrefe M Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804 [TBL] [Abstract][Full Text] [Related]
15. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk. Kamath GS; Mittal S; Sherrid MV Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():32-40. PubMed ID: 20089485 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy. Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378 [TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death. Yin K; Ding L; Li Y; Hua W Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837 [TBL] [Abstract][Full Text] [Related]
18. [Hereditary risk of sudden cardiac death--genetic investigation of the family]. Lundin C; Platonov P; Kristoffersson U Lakartidningen; 2009 Apr 7-21; 106(15-16):1089-93. PubMed ID: 19492675 [No Abstract] [Full Text] [Related]
19. Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience. Wong LC; Roses-Noguer F; Till JA; Behr ER Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):800-6. PubMed ID: 25194972 [TBL] [Abstract][Full Text] [Related]
20. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death. Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]